Antinuclear antibodies in open-angle glaucoma.
D000086:Acetazolamide / Q000627:therapeutic use; D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000818:Animals; D000974:Antibodies, Antinuclear / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D001344:Autopsy; D001485:Basement Membrane / Q000276:immunology; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D004947:Esophagus / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D005901:Glaucoma / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D006041:Goats / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G; D008099:Liver / Q000276:immunology; D008297:Male; D051379:Mice; D008875:Middle Aged; D010641:Phenotype; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007074:Immunoglobulin G; D010862:Pilocarpine; D000086:Acetazolamide; D004837:Epinephrine